CytoMed Therapeutics News

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 7 07:48 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 3 07:02 ET

CytoMed Therapeutics | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)

Jun 24 13:45 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 20 13:52 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 18 06:05 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 4 06:20 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 29 07:03 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 25, 2023 08:29 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 1, 2023 07:35 ET

CytoMed Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jul 6, 2023 07:46 ET

CytoMed Therapeutics | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Mar 30, 2023 13:27 ET

CytoMed Therapeutics | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Mar 27, 2023 17:54 ET

CytoMed Therapeutics | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Mar 15, 2023 20:33 ET

CytoMed Therapeutics | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Feb 21, 2023 14:54 ET

CytoMed Therapeutics | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Jan 31, 2023 19:29 ET

CytoMed Therapeutics | F-1: Registration statement for securities of certain foreign private issuers

Nov 18, 2022 09:54 ET